Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Meeting ID

<< Previous

Bullboard Posts

Next >>

Comment by menoalittleon Dec 04, 2024 12:28pm

192 Views

Post# 36345402

RE:RE:RE:RE:RE:Meeting ID

Sure sounds to me like they will be submitting for actual BTD later this month, with (presuming the FDA gives it the nod) possible approval as early as late January. (Would certainly make a heck of a nice valentines day present...)

<< Previous

Bullboard Posts

Next >>

Invest wiser with BMO's InvestorLine Platform features